China Pete & Chem (SNP) Stock Price Rose While U S Global Investors Lifted Its Stake; Repligen (RGEN) Holder Cortina Asset Management Cut Position as Stock Value Rose

November 15, 2017 - By Peter Erickson

U S Global Investors Inc increased its stake in China Pete & Chem Corp (SNP) by 435.03% based on its latest 2017Q2 regulatory filing with the SEC. U S Global Investors Inc bought 14,356 shares as the company’s stock rose 4.36% with the market. The institutional investor held 17,656 shares of the integrated oil company at the end of 2017Q2, valued at $1.39M, up from 3,300 at the end of the previous reported quarter. U S Global Investors Inc who had been investing in China Pete & Chem Corp for a number of months, seems to be bullish on the $105.84 billion market cap company. It closed at $71.68 lastly. It is down 24.29% since November 15, 2016 and is uptrending. It has outperformed by 7.59% the S&P500.

Cortina Asset Management Llc decreased its stake in Repligen Corp (RGEN) by 7.8% based on its latest 2017Q2 regulatory filing with the SEC. Cortina Asset Management Llc sold 14,444 shares as the company’s stock rose 23.50% with the market. The institutional investor held 170,633 shares of the biological products (no diagnostic substances) company at the end of 2017Q2, valued at $7.07M, down from 185,077 at the end of the previous reported quarter. Cortina Asset Management Llc who had been investing in Repligen Corp for a number of months, seems to be less bullish one the $1.42B market cap company. It closed at $32.53 lastly. It is down 59.96% since November 15, 2016 and is uptrending. It has outperformed by 43.26% the S&P500.




Analysts await Repligen Corporation (NASDAQ:RGEN) to report earnings on February, 28. They expect $0.14 EPS, up 75.00% or $0.06 from last year’s $0.08 per share. RGEN’s profit will be $6.11M for 58.09 P/E if the $0.14 EPS becomes a reality. After $0.15 actual EPS reported by Repligen Corporation for the previous quarter, Wall Street now forecasts -6.67% negative EPS growth.

Investors sentiment increased to 2.06 in 2017 Q2. Its up 0.99, from 1.07 in 2017Q1. It improved, as 9 investors sold RGEN shares while 44 reduced holdings. 39 funds opened positions while 70 raised stakes. 33.17 million shares or 7.05% more from 30.98 million shares in 2017Q1 were reported. Benin Management Corp invested 0.09% of its portfolio in Repligen Corporation (NASDAQ:RGEN). Nationwide Fund Advisors reported 82,501 shares. First Manhattan Communications has 0% invested in Repligen Corporation (NASDAQ:RGEN) for 8,500 shares. Rice Hall James And Lc stated it has 0.12% in Repligen Corporation (NASDAQ:RGEN). Goldman Sachs holds 258,287 shares or 0% of its portfolio. Royal National Bank & Trust Of Canada accumulated 35,146 shares. Comerica Bank reported 0.01% in Repligen Corporation (NASDAQ:RGEN). Zurcher Kantonalbank (Zurich Cantonalbank) owns 1,159 shares. State Board Of Administration Of Florida Retirement reported 0% stake. Bank & Trust Of Ny Mellon Corporation holds 0.01% of its portfolio in Repligen Corporation (NASDAQ:RGEN) for 451,927 shares. Dimensional Fund Advsrs LP holds 895,872 shares or 0.02% of its portfolio. Oppenheimer Asset Mngmt Incorporated stated it has 0% in Repligen Corporation (NASDAQ:RGEN). Loomis Sayles And Lp holds 0% or 223 shares. Schwab Charles Investment Management accumulated 0.01% or 215,450 shares. Sandler Capital holds 0.99% or 221,070 shares in its portfolio.

Among 5 analysts covering Repligen (NASDAQ:RGEN), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Repligen had 10 analyst reports since November 6, 2015 according to SRatingsIntel. Craig Hallum initiated the stock with “Buy” rating in Monday, February 22 report. The rating was maintained by Jefferies with “Hold” on Thursday, August 3. Jefferies downgraded the stock to “Hold” rating in Friday, November 6 report. Jefferies maintained Repligen Corporation (NASDAQ:RGEN) rating on Tuesday, June 27. Jefferies has “Hold” rating and $4000 target. The rating was upgraded by Piper Jaffray to “Overweight” on Monday, February 13. On Wednesday, October 18 the stock rating was maintained by Jefferies with “Hold”. As per Friday, July 21, the company rating was initiated by William Blair. The stock has “Hold” rating by Jefferies on Thursday, June 8. The stock has “Hold” rating by Jefferies on Tuesday, September 12.

More important recent Repligen Corporation (NASDAQ:RGEN) news were published by: Globenewswire.com which released: “Repligen Reports Third Quarter 2017 Financial Results” on November 09, 2017, also Zacks.com published article titled: “Should You Sell Repligen Corporation (RGEN) Before Earnings? November 08, 2017”, Globenewswire.com published: “Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands” on November 07, 2017. More interesting news about Repligen Corporation (NASDAQ:RGEN) was released by: Seekingalpha.com and their article: “Repligen’s (RGEN) CEO Tony Hunt on Q3 2017 Results – Earnings Call Transcript” with publication date: November 11, 2017.

Cortina Asset Management Llc, which manages about $2.83B and $2.36B US Long portfolio, upped its stake in Healthequity Inc (NASDAQ:HQY) by 20,542 shares to 450,504 shares, valued at $22.45M in 2017Q2, according to the filing. It also increased its holding in Pacira Pharmaceuticals Inc (NASDAQ:PCRX) by 24,014 shares in the quarter, for a total of 243,860 shares, and has risen its stake in Forum Energy Technologies (NYSE:FET).

Among 5 analysts covering China Petroleum & Chemical Corp (NYSE:SNP), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. China Petroleum & Chemical Corp had 7 analyst reports since August 26, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, August 26 by HSBC. On Friday, September 11 the stock rating was upgraded by Jefferies to “Hold”. As per Tuesday, March 29, the company rating was downgraded by Credit Suisse. The firm earned “Buy” rating on Wednesday, March 2 by Mizuho. Jefferies upgraded the shares of SNP in report on Wednesday, September 30 to “Buy” rating. The rating was downgraded by Macquarie Research to “Neutral” on Thursday, November 12. The rating was upgraded by Citigroup to “Sell” on Friday, August 28.

Another recent and important China Petroleum & Chemical Corp (ADR) (NYSE:SNP) news was published by Prnewswire.com which published an article titled: “China Petroleum & Chemical Corporation Files 2016 Annual Report on Form 20-F” on April 25, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.